Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.115170 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Yaochen Lou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of…. Hauptthemen laut MEDLINE: WAP Four-Disulfide Core Domain Protein 2, Endometrial Neoplasms, Fertility Preservation, Endometrial Hyperplasia. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433, Shanghai, Chi…
- Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, 210029, Nanjing, China.
- Department of Neonatology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433, Shanghai, Ch…
Zitieren
APA
Lou, Y., Ma, W., Jiang, F., & Guan, J. (2025). Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.115170
Vancouver
Lou Y, Ma W, Jiang F, Guan J. Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.115170
BibTeX
@article{Lou2025,
author = {Lou, Yaochen and Ma, Weirong and Jiang, Feng and Guan, Jun},
title = {Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.115170}
}
EUVIMED